Clinical Trial Update: Phase II Randomised Trial of Cyclophosphamide & Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma. [Phase 2]

View source ↗

Summary

Phase II randomized trial evaluating cyclophosphamide and dexamethasone with ixazomib in relapsed or refractory multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• ixazomib (ixazomib)

Snippet

Sponsor: University of Leeds | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED